Symptom Experience and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy – A Secondary Publication
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Chemotherapy
Colorectal neoplasms
Quality of life
Symptoms

DOI

10.26689/par.v8i1.6104

Submitted : 2024-01-23
Accepted : 2024-02-07
Published : 2024-02-22

Abstract

Objective: To evaluate symptom experience and quality of life (QoL) and to identify the predictors of QoL among colorectal cancer patients undergoing chemotherapy. Methods: A cross-sectional study was conducted on 107 colorectal cancer patients at a university-affiliated hospital between June 1 and July 30, 2021. Functional Assessment of Cancer Therapy-Colorectal (FACT-C) and Memorial Symptom Assessment Scale-Short Form (MSAS-SF) were used to assess symptom experience and QoL of these patients. Data were analyzed using Pearson’s correlation, t-test, ANOVA, and hierarchical multiple regression. Results: The mean QoL score for colorectal cancer patients was 88.78 ± 20.08. The most frequently experienced physical and psychological symptoms were numbness/tingling and worrying. Physical and psychological symptoms have a significant negative association with QoL. Perceived economic status was significantly associated with QoL in patients’ general characteristics. The regression analyses showed that high psychological symptoms (β = -0.63, P < 0.001), middle perceived economic status (β = -0.22, P = 0.009), and low perceived economic status (β = -0.36, P < 0.001) were statistically significant in predicting patients’ low QoL. Conclusion: Symptom experience and QoL are essential variables that should be acknowledged when delivering health care to colorectal cancer patients. More attention to the reduction and comprehensive symptom management of psychological distress could improve QoL among colorectal cancer patients.

References

Korean National Cancer Center, 2019, Annual Report of Cancer Statistics in Korean 2019. Viewed July 30, 2022, https://ncc.re.kr/cancerStatsView.ncc?bbsnum=578&searchKey

Benson AB 3rd, Venook AP, Al-Hawary MM, et al., 2018, Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 16(7): 874–901. https://doi.org/10.6004/jnccn.2018.0061

Han CJ, Yang GS, Syrjala K, 2020, Symptom Experiences in Colorectal Cancer Survivors After Cancer Treatments: A Systematic Review and Meta-Analysis. Cancer Nurs, 43(3): E132–E158. https://doi.org/10.1097/NCC.0000000000000785

Cella DF, Tulsky DS, 1993, Quality of Life in Cancer: Definition, Purpose, and Method of Measurement. Cancer Invest, 11(3): 327–336. https://doi.org/10.3109/07357909309024860

AlFayyad I, Al-Tannir M, Howaidi J, et al., 2022, Health-Related Quality of Life of Breast and Colorectal Cancer Patients Undergoing Active Chemotherapy Treatment: Patient-Reported Outcomes. Qual Life Res, 31(9): 2673–2680. https://doi.org/10.1007/s11136-022-03145-8

André T, Vernerey D, Mineur L, et al., 2018, Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. J Clin Oncol, 36(15): 1469–1477. https://doi.org/10.1200/JCO.2017.76.0355

Lu L-C, Tsay S-L, Chang S-Y, et al., 2019, Daily Activity, Mood, and Quality of Life in Colorectal Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Mediation Effect Analysis. Cancer Med, 8(3): 963–971. https://doi.org/10.1002/cam4.1976

Soveri LM, Lamminmäki A, Hänninen UA, et al., 2019, Long-Term Neuropathy and Quality of Life in Colorectal Cancer Patients Treated with Oxaliplatin Containing Adjuvant Chemotherapy. Acta Oncol, 58(4): 398–406. https://doi.org/10.1080/0284186X.2018.1556804

Go?dziewicz B, Struga?a M, Talarska D, et al., 2017, Functioning of People with Colorectal Cancer During Chemotherapy. Demographic and Clinical Determinants of Quality of Life of Patients with Colorectal Cancer Receiving Chemotherapy. Pilot Study. Eur J Cancer Care (Engl), 26(3): e12616. https://doi.org/10.1111/ecc.12616

Röhrl K, Guren MG, Astrup GL, et al., 2020, High Symptom Burden is Associated with Impaired Quality of Life in Colorectal Cancer Patients During Chemotherapy: A Prospective Longitudinal Study. Eur J Oncol Nurs, 44: 101679. https://doi.org/10.1016/j.ejon.2019.101679

Röhrl K, Guren MG, Småstuen MC, et al., 2019, Symptoms During Chemotherapy in Colorectal Cancer Patients. Support Care Cancer, 27(8): 3007–3017. https://doi.org/10.1007/s00520-018-4598-y

Meng X, Wang X, Dong Z, 2021, Impact of Non-Pharmacological Interventions on Quality of Life, Anxiety, and Depression Scores in Patients with Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Support Care Cancer, 29(10): 5635–5652. https://doi.org/10.1007/s00520-021-06185-x

Choi KS, Park JA, Lee J, 2012, The Effect of Symptom Experience and Resilience on Quality of Life in Patients with Colorectal Cancers. Asian Oncol Nurs, 12(1): 61–68. https://doi.org/10.5388/aon.2012.12.1.61

Kim EH, Suh SR, 2018, A Longitudinal Path Analysis of Symptom, Fatigue and Quality of Life in Patients with Colorectal Cancer During Chemotherapy. J Health Info Stat, 43(3): 200–207. https://doi.org/10.21032/jhis.2018.43.3.200

Taghizadeh A, Pourali L, Vaziri Z, et al., 2018, Psychological Distress in Cancer Patients. Middle East J Cancer, 9(2): 143–149. https://doi.org/10.30476/mejc.2018.42116

Schuurhuizen CSEW, Braamse AMJ, Konings IRHM, et al., 2017, Does Severe Toxicity Affect Global Quality of Life in Patients with Metastatic Colorectal Cancer During Palliative Systemic Treatment? A Systematic Review. Ann Oncol, 28(3): 478–486. https://doi.org/10.1093/annonc/mdw617

Chang VT, Hwang SS, Feuerman M, et al., 2000, The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer, 89(5): 1162–1171. https://doi.org/10.1002/1097-0142(20000901)89:5<1162::aid-cncr26>3.0.co;2-y

Nho J-H, Kim SR, Chang VT, et al., 2018, Reliability and Validity of the Korean Memorial Symptom Assessment Scale-Short Form in Gynecological Cancer Patients. J Pain Symptom Manage, 55(1): 101–107. https://doi.org/10.1016/j.jpainsymman.2017.08.023

Lam WWT, Law CC, Fu YT, et al., 2008, New Insights in Symptom Assessment: The Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). J Pain Symptom Manage, 36(6): 584–595. https://doi.org/10.1016/j.jpainsymman.2007.12.008

Ward WL, Hahn EA, Mo F, et al., 1999, Reliability and Validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) Quality of Life Instrument. Qual Life Res, 8(3): 181–195. https://doi.org/10.1023/a:1008821826499

Lewis C, Xun P, He K, 2016, Effects of Adjuvant Chemotherapy on Recurrence, Survival, and Quality of Life in Stage II Colon Cancer Patients: A 24-month Follow-Up. Support Care Cancer, 24(4): 1463–1471. https://doi.org/10.1007/s00520-015-2931-2

Tang H, Besson A, Deftereos I, et al.,2022, The Health-Related Quality of Life Changes Following Surgery in Patients with Colorectal Cancer: A Longitudinal Study. ANZ J Surg, 92(6): 1461–1465. https://doi.org/10.1111/ans.17602

Tantoy IY, Cooper BA, Dhruva A, et al., 2018, Changes in the Occurrence, Severity, and Distress of Symptoms in Patients with Gastrointestinal Cancers Receiving Chemotherapy. J Pain Symptom Manage, 55(3): 808–834. https://doi.org/10.1016/j.jpainsymman.2017.10.004

Hofsø K, Rustøen T, Cooper BA, et al., 2013, Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer. J Pain Symptom Manage, 45(6): 980–1006. https://doi.org/10.1016/j.jpainsymman.2012.06.003

Kim H, Yoo Y-S, 2021, Factors Influencing Supportive Care Needs of Colorectal Cancer Survivors. Asian Nurs Res (Korean Soc Nurs Sci), 15(1): 60–66. https://doi.org/10.1016/j.anr.2020.11.003

Mols F, Schoormans D, de Hingh I, et al., 2018, Symptoms of Anxiety and Depression Among Colorectal Cancer Survivors from the Population-Based, Longitudinal PROFILES Registry: Prevalence, Predictors, and Impact on Quality of Life. Cancer, 124(12): 2621–2628. https://doi.org/10.1002/cncr.31369

Drury A, Payne S, Brady A-M, 2020, Identifying Associations Between Quality of Life Outcomes and Healthcare-Related Variables Among Colorectal Cancer Survivors: A Cross-Sectional Survey Study. Int J Nurs Stud, 101: 103434. https://doi.org/10.1016/j.ijnurstu.2019.103434

Trudel-Fitzgerald C, Tworoger SS, Poole EM, et al., 2018, Psychological Symptoms and Subsequent Healthy Lifestyle After a Colorectal Cancer Diagnosis. Health Psychol, 37(3): 207–217. https://doi.org/10.1037/hea0000571

Son H, Son Y-J, Kim H, et al., 2018, Effect of Psychosocial Interventions on the Quality of Life of Patients with Colorectal Cancer: A Systematic Review and Meta-Analysis. Health Qual Life Outcomes, 16(1): 119. https://doi.org/10.1186/s12955-018-0943-6

Sharp L, O’Leary E, O’Ceilleachair A, et al., 2018, Financial Impact of Colorectal Cancer and Its Consequences: Associations Between Cancer-Related Financial Stress and Strain and Health-Related Quality of Life. Dis Colon Rectum, 61(1): 27–35. https://doi.org/10.1097/DCR.0000000000000923